This is a friendly reminder that we’re seeking input on how institutions monitor the impact of research outputs. Take our citation & impact reporting survey:
https://form.typeform.com/to/G3Vrf7vi

#DataCite #CitationTracking #ResearchImpact #ImpactReporting #ResearchOutputs #ScholarlyCommunication #OpenScience #ResearchInfrastructure #PIDs #DOI #Metadata #FAIRdata #CommunityInput

Survey on Citation Tracking and Reporting

Help improve citation reporting at DataCite.

DataCite now has a new endpoint for enriched DOI metadata records.
How would you like to contribute or retrieve enriched metadata in the future? Explore the new endpoint and share your thoughts in the survey:
https://github.com/datacite/datacite-suggestions/discussions/236
https://form.typeform.com/to/Ektmjgg3

#DataCite #Metadata #PersistentIdentifiers #PIDs #DOI #OpenScience #ResearchInfrastructure #ScholarlyCommunication #FAIRdata #MetadataQuality #OpenInfrastructure #ResearchData #CommunityInput

Kommende Woche bin ich auf der #BiblioCon26 und gebe Einblicke in die nationale Roadmap zur Nutzung und Verbreitung von Persistenten Identifikatoren #PIDs in Deutschland.

Aktuell ist die Roadmap in einer öffentlichen Kommentierungsphase
👉 https://tinyurl.com/bdhjtxhz

📆 Do, 21. Mai, 11:00 – 12:30
📍 Raum V / 5
👀 Persistente Identifikatoren als Fundament unserer Wissenslandschaft: Die PID-Roadmap für Deutschland

#BiblioCON #FAIR #FDM @bibliocon #OpenScience #PIDNetwork @paul4kant @AntoniaS

Die Roadmap enthält Empfehlungen zur Weiterentwicklung einer vernetzten, nachhaltigen PID-Landschaft in Deutschland – von lokalen Anwendungen bis hin zu systemischen Effekten einer breiten Nutzung.

Jetzt sind eure Perspektiven gefragt: Welche Empfehlungen sind besonders relevant? Wo gibt es Lücken oder Ergänzungsbedarf?

📅 Kommentierung bis 10. Juni 2026
✏️ https://docspace-s7k23k.onlyoffice.com/s/rXdFTjPHtDJLvx5

#PIDs #PersistentIdentifier #FDM #FAIR #OpenScience #OpenData #RDM #PIDNetwork

What does it mean to be a DataCite member? Why should you consider joining? We answered these questions & more in our new Membership Essentials webinar series.
ICYMI, watch the recording to learn about DataCite membership pathways, services, governance, fees & how to get started
https://youtu.be/206BZd-5fA4
#DataCite
#PersistentIdentifiers
#PIDs
#DOI
#OpenInfrastructure
#OpenScience
#ResearchData
#ScholarlyCommunication
#ResearchInfrastructure
#Metadata
#CommunityGovernance
#Membership
#PIDCommunity

Since 2024, DataCite's Global Access Fund has supported 20 projects expanding equitable access to DataCite infrastructure. See how training, outreach, and infrastructure development in regions where PID adoption is still emerging are helping to build a more open, global community: https://doi.org/10.5438/29r5-rk13

@Mohamadmostafa
#DataCite
#GlobalAccessFund
#PersistentIdentifiers
#PIDs
#OpenInfrastructure
#OpenScience
#EquitableAccess
#PIDAdoption
#ScholarlyCommunication
#ResearchData
#FAIRData

#OpenPharma just published a vision statement calling on #pharma companies to make their research #OpenAccess.
https://bmjopen.bmj.com/content/16/5/e104128

The vision statement calls for OpenAccess to texts, #OpenData (under #FAIR principles), open #PIDS (#ORCID and #ROR), plain language summaries, and patient involvement.

It understands that the goal is a stretch. and distinguishes easier short-term goals from harder long-term goals, while arguing for both.

OpenPharma is funded by voluntary contributions from pharma companies, and considers itself a collaboration of "a number of important stakeholder groups: the pharmaceutical industry, publishers, patients, academics, regulators, editors, non-pharmaceutical funders and societies."
https://www.openpharma.blog/wp-content/uploads/2021/02/2020-01-15-Charter-of-Open-Pharma.pdf

Also see the OpenPharma home page.
https://www.openpharma.blog/

#Medicine #OpenScience #ScholComm

An Open Pharma Vision for company-sponsored biomedical research publications

Open Science aims to fight misinformation and improve trust in scientific research; it encourages the reliability and accessibility of evidence, reduces inequalities through the democratisation of scientific knowledge and focuses scientific endeavours on issues of societal significance. As a multisponsor collaboration committed to driving positive change, Open Pharma has a multifaceted vision for scientific research publications funded by pharmaceutical companies (‘company research publications’) that aligns strongly with Open Science tenets. This new vision statement outlines our forward-looking principles for company research publications, both for short-term attainment (‘immediate’) and long-term commitment (‘ultimate’). Together, the principles provide a framework for positive collective action by all stakeholders involved in the development and dissemination of peer-reviewed company research publications. Underpinned by our central commitment to transparency for company research publications, we outline goals for: universal access to these publications; provision of peer-reviewed plain language summaries of the publications to aid comprehension among non-specialist readers; leveraging author and institutional metadata to advance transparency, discoverability and research impact; working towards FAIR (Findability, Accessibility, Interoperability, and Reuse) data principles through cross-sector consensus and action, and disclosure of patient involvement in research and its reporting to support transparency and encourage a research ecosystem attuned to patient centricity. We call on all stakeholders to realise the Open Pharma Vision and achieve an open and trusted future for company research publications that will ultimately advance patient care and improve global health.

BMJ Open

DataCite welcomes 4 newly elected Board members:
Bessem Aamira, Véronique Stoll, José Benito González López, and Merilen Ivask-Oprelianska.
We also thank outgoing Board members for their years of service to DataCite’s mission & community.
Learn more about them on our blog: https://doi.org/10.5438/57p9-jm78

#DataCite #OpenScience #OpenResearch #ResearchInfrastructure #OpenInfrastructure #ScholarlyCommunication #PersistentIdentifiers #PIDs #DOI #CommunityGovernance #ResearchCommunity #BoardElections

We’re seeking community input on future additions to the DataCite Metadata Schema:
- a proposed new Access property: https://github.com/datacite/datacite-suggestions/discussions/235
- an updated definition for resourceTypeGeneral “Book”: https://github.com/datacite/datacite-suggestions/discussions/234
Please share your feedback by 12 May.🙌

#DataCite #Metadata #MetadataSchema #PersistentIdentifiers #PIDs #DOI #OpenScience #OpenResearch #ScholarlyCommunication #CommunityFeedback #FAIRData #ResearchInfrastructure #CommunityDriven #OpenInfrastructure

Request for comment: New Access property · datacite datacite-suggestions · Discussion #235

Currently, the DataCite Metadata Schema doesn’t have a specific way to include information about the access rights (or availability) of a resource. Specifically, we have heard that: Harvesters want...

GitHub

Heading to the #CoSector Festival of Technology in London on 5 May?
The research ecosystem is only as strong as its connections 🔗Look for ORCID's Shivendra Naidoo who will be on hand to talk #PIDs and #researchinfrastructure.

👉 More here:
https://www.cosector.com/festival/#ORCIDisEverywhere